Genetic evidence that Nkx2.2 acts primarily downstream of Neurog3 in pancreatic endocrine lineage development.

Churchill AJ, Gutiérrez GD, Singer RA, Lorberbaum DS, Fischer KA, Sussel L. · 2017

Read Genetic evidence that Nkx2.2 acts primarily downstream of Neurog3 in pancreatic endocrine lineage development. by Churchill AJ, Gutiérrez GD, Singer RA, Lorberbaum DS, Fischer KA, Sussel L. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5224921.txt.

Introduction

Angela J. Churchill, Giselle Dominguez Gutiérrez, Ruth A. Singer, David S. Lorberbaum, Kevin A. Fischer, and Lori Sussel used mouse genetics to order two pancreas transcription factors in eLife in 2017. The pancreas makes hormone-producing islet cells, including insulin-making beta cells, through a chain of progenitor stages. Two switches, Neurog3 and Nkx2.2, are both essential, but which one directs the other was unclear.

The team deleted Nkx2.2 only in cells that had switched on Neurog3, the marker of endocrine progenitors. Many beta cell network genes that collapse in full Nkx2.2 knockout mice stayed normal in these mice, yet beta cell development still failed in the same way. That pattern places Nkx2.2 mainly downstream of Neurog3 while also showing it has extra essential work inside the endocrine progenitors themselves. The authors describe Nkx2.2 as part of a modular program that assigns islet cell fates.

Catalog record

CREATORChurchill AJ, Gutiérrez GD, Singer RA, Lorberbaum DS, Fischer KA, Sussel L.
YEAR2017
COLLECTIONPAPERS
FORMATTXT
FILE SIZE62 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5224921

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Genetic evidence that Nkx2.2 acts primarily downstream of Neurog3 in pancreatic endocrine lineage development By Angela J Churchill, Giselle Dominguez Gutiérrez, Ruth A Singer, David S Lorberbaum, Kevin A Fischer, Lori Sussel, Clare Blackburn Published in: eLife DOI: 10.7554/eLife.20010 ABSTRACT Many pancreatic transcription factors that are essential for islet cell differentiation have been well characterized; however, because they are often expressed in several different cell populations, their functional hierarchy remains unclear. To parse out the spatiotemporal regulation of islet cell differentiation, we used a Neurog3-Cre allele to ablate Nkx2.2, one of the earliest and most broadly expressed islet transcription factors, specifically in the Neurog3+ endocrine progenitor lineage (Nkx2.2△endo). Remarkably, many essential components of the β cell transcriptional network that were down-regulated in the Nkx2.2KO mice, were maintained in the Nkx2.2△endo mice - yet the Nkx2.2△endo mice displayed defective β cell differentiation and recapitulated the Nkx2.2KO phenotype. This suggests that Nkx2.2 is not only required in the early pancreatic progenitors, but has additional essential activities within the endocrine progenitor population. Consistently, we demonstrate Nkx2.2 functions as an integral component of a modular regulatory program to correctly specify pancreatic islet cell fates. DOI: http://dx.doi.org/10.7554/eLife.20010.001 INTRODUCTION The pancreas is an essential dual-functioning organ that contains an exocrine and endocrine compartment. The exocrine pancreas represents the majority of the pancreatic tissue and contains acinar cells that secrete digestive enzymes and the ductal cells through which the enzymes are transported into the duodenum. The endocrine pancreas only represents 1–2% of the organ, but is comprised of hormone-producing islet cells that are critical for the maintenance of glucose homeostasis. Interestingly, although these two compartments have highly disparate functions, they arise from a common multipotent progenitor population that gradually forms spatially and molecularly distinct progenitor subpopulations during development (Burlison et al., 2008; Offield et al., 1996; Pan and Wright, 2011; Zhou et al., 2007). A bi-potent duct/endocrine progenitor population is then derived from the multipotent progenitor population and subsequently differentiates into a highly restricted endocrine progenitor population that produces all islet cell types, including the functionally important insulin-producing β cell lineage. The progressive restriction of progenitor-cell lineage potential to ultimately give rise to pancreatic islet cells is believed to be regulated by the sequential expression of several essential transcription factors. The multipotent progenitor population is defined by the expression of Pancreatic and duodenal homeobox 1 (Pdx1) and Pancreas transcription factor 1a (Ptf1a), transcriptional regulators that are essential for pancreatic formation; deletion of Pdx1 or Ptf1a leads to pancreatic agenesis (Burlison et al., 2008; Gu et al., 2003; Jonsson et al., 1994; Kawaguchi et al., 2002; Offield et al., 1996). A subset of cells from the Pdx1+ Ptf1a+ multipotent progenitors gradually become restricted to the endocrine lineage with the expression of Neurogenin 3 (Neurog3), which delineates the endocrine progenitor population. Neurog3 is essential for the formation of all six embryonic pancreatic endocrine cell types: the insulin-producing β cells, glucagon-producing α cells, somatostatin-producing δ cells, pancreatic polypeptide-producing PP cells, gastrin-producing G cells, and ghrelin-producing ε cells (Gradwohl et al., 2000; Gu et al., 2002; Heller et al., 2005; Schwitzgebel et al., 2000; Suissa et al., 2013). Mice lacking Neurog3 almost completely fail to form these endocrine lineages (Gradwohl et al., 2000; Heller et al., 2005; Suissa et al., 2013). Although it is well-established that β cells are derived from the Neurog3+ progenitor lineage, there is still some uncertainty about when and where the β cell lineage is specified during pancreas development. β cell fate may be influenced early within the Pdx1+ pancreatic progenitor to specify unipotent populations of Neurog3+ endocrine progenitor cells (Desgraz and Herrera, 2009) or it may be occurring within the Neurog3+ endocrine progenitor lineage after induction of Neurog3. Interestingly, Johansson et al. (2007) demonstrated that pancreatic progenitor cells transition through distinct competence windows in response to Neurog3 induction for each endocrine cell fate, with β cell competence being acquired during a window of development between embryonic day (E)10.5 and E16 (Johansson et al., 2007). Many of the transcription factors that are essential for β cell specification have been identified, including Nkx2.2, Nkx6.1, Rfx6, Glis3, Insm1 and Neurod1; however, we still have an incomplete understanding of how these factors regulate the timing and mechanism of β cell fate induction since they are often expressed both early and throughout pancreas development and are not always restricted to the β cell lineage. For example, Nkx2.2, Nkx6.1 and Rfx6 are expressed in multipotent pancreatic progenitors and endocrine progenitors, in addition to their maintained expression in several of the mature endocrine lineages (Arnes et al., 2012b; Jørgensen et al., 2007; Pedersen et al., 2005; Soyer et al., 2010). Glis3 expression is first detected in the bipotent progenitor cells, but is then maintained in the preductal and endocrine progenitors, and ultimately restricted to the β, PP and ductal lineages (Kang et al., 2016). Insm1 is similarly expressed in the pancreatic pre-endocrine cells, endocrine progenitor cells and is maintained in all endocrine cell types (Gierl et al., 2006; Mellitzer et al., 2006; Osipovich et al., 2014). Lastly, Neurod1 can be detected as early as E9.5 in the early glucagon and ghrelin producing cells, but predominantly becomes restricted first to endocrine progenitors and then is maintained in all endocrine lineages (Anderson et al., 2009a; Naya et al., 1997). Null mutations of all six of these transcriptional regulators cause neonatal lethality likely due to their severe defects in β cell development (Gierl et al., 2006; Naya et al., 1997; Osipovich et al., 2014; Prado et al., 2004; Smith et al., 2010; Sussel et al., 1998); however, it is unknown exactly when each of these factors exerts their functional role in β cell fate specification. To gain a better understanding of both the timing and mechanism of β cell fate induction we chose to focus on the essential islet transcription factor, Nkx2.2. Nkx2.2 is a critical regulator of appropriate islet cell lineage specification during pancreagenesis; mice carrying an Nkx2.2 null mutation form reduced numbers of α and β cells and instead form increased numbers of ghrelin-producing ε cells due to defects in cell lineage specification (Prado et al., 2004; Sussel et al., 1998). Importantly, β cell fate specification is completely dependent on Nkx2.2 as no β cells are formed in mice carrying a null mutation in Nkx2.2 (Nkx2.2KO) (Sussel et al., 1998). Nkx2.2 is co-expressed with Pdx1 throughout the pancreatic progenitor domain, but its expression becomes restricted to the Neurog3+ endocrine progenitor population (Arnes et al., 2012b; Jørgensen et al., 2007; Sussel et al., 1998). Nkx2.2 also appears to function at or near the top of the regulatory cascade of transcription factors to specify β cell fate: The expression of Neurog3, Nkx6.1, Rfx6 and Neurod1 was significantly reduced in Nkx2.2KO progenitor populations (Anderson et al., 2009a, 2009b; Chao et al., 2007) (Table 1), suggesting that Nkx2.2 functions within the pancreatic epithelium to influence the derivation of endocrine-committed cells that can enter the appropriate endocrine lineage pathways.10.7554/eLife.20010.002Table 1.NKx2.2Δendo and Nkx2.2KO E15.5 RNA-Seq - Gene expression changes in select transcription factors and pancreatic hormones.DOI: http://dx.doi.org/10.7554/eLife.20010.002Nkx2.2△endo fold change Adjusted p-value Nkx2.2KO fold change Adjusted p-value Transcription factors Arx2.163.26E-091.570.0031MafA0.113.39E-060.130.0040MafB0.431.31E-100.223.92E-38NeuroD10.8910.323.01E-23Neurog31.1110.590.0198Nkx6.10.7710.820.9684Pax41.0210.730.4762Pax60.361.07E-060.212.84E-30Pdx10.8811.250.7916Rfx61.0010.630.0013Sox90.9411.081Pancreatic hormones Gast0.192.16E-070.092.63E-09Gcg0.162.23E-120.014.64E-16Ghrl8.271.94E-316.436.72E-16Ins10.034.84E-240.004.32E-11Ins20.012.99E-550.001.48E-11Ppy10.084.99E-422.177.15E-05Sst1.1410.450.5130 The early expression of Nkx2.2 within the multipotent progenitor population, upstream of Neurog3 prompted us to determine whether Nkx2.2

Read the complete text